RxDoctor Payments Data

Megan Payne

Medical · Lutherville, MDNPI 1134622095

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $12,847 of the $19,060 with a category attached, or 67.4%. 23 manufacturers reported payments, led by Arcutis Biotherapeutics, Inc. at 26.7% of the total. Reporting peaked in 2023 at $8,976 and has fallen 74.3% since, to $2,309 in 2025. Among medical clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$19,060in general payments, 2019–2025

Across 724 payments — averaging $26.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arcutis Biotherapeutics, Inc.$5K
  • Johnson & Johnson$4K
  • AbbVie$2K
  • Incyte Corporation$2K
  • E.r. Squibb & Sons, L.L.C.$1K
  • Sun Pharmaceutical Industries Inc.$1K
  • plus $4K from 17 others

What the payments were for

  • Consulting fees$4,89526%
  • Travel & lodging$9625%
  • Food & beverage$12,84767%
  • Education$3552%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,060 in reported general payments places this provider in the 95th percentile of 543 medical providers in Maryland.

See all medical providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab13$49,036
OpzeluraRuxolitinib Phosphate16$36,958
Clobetasol Propionate136$5,396
Ketoconazole168$3,029
Doxycycline Hyclate58$2,738
Metronidazole41$1,686
Triamcinolone Acetonide147$1,222
Tacrolimus12$686
Clindamycin Phosphate18$654
Fluorouracil12$613
Tretinoin15$568
Ciclopirox12$276
ValacyclovirValacyclovir Hcl18$270
Mupirocin25$244
Hydrocortisone26$73

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Incyte CorporationOpzelura$1,627$36,95816 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 543 medical providers in Maryland.

Other medical in Lutherville

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →